SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000313616-20-000079
Filing Date
2020-04-01
Accepted
2020-04-01 07:18:35
Documents
18
Period of Report
2020-03-31
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biopharma8-k.htm   iXBRL 8-K 77607
2 GE BIOPHRMA PURCHASE AGREEMENT ex-21purchaseagreement.htm EX-2.1 1080857
3 CONSENT OF KPMG LLP, INDEPENDENT AUDITORS ex-231consentofkpmg.htm EX-23.1 3099
4 AUDITED FINANCIAL STATEMENTS OF GE BIOPHARMA ex-992auditedannualcom.htm EX-99.1 974380
10 dhrlogofor8ksa22.jpg GRAPHIC 8569
  Complete submission text file 0000313616-20-000079.txt   2679076

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dhr-20200331.xsd EX-101.SCH 7118
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dhr-20200331_cal.xml EX-101.CAL 629
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dhr-20200331_def.xml EX-101.DEF 21183
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dhr-20200331_lab.xml EX-101.LAB 51501
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dhr-20200331_pre.xml EX-101.PRE 23875
16 EXTRACTED XBRL INSTANCE DOCUMENT biopharma8-k_htm.xml XML 21885
Mailing Address 2200 PENNSYLVANIA AVE. N.W. SUITE 800W WASHINGTON DC 20037-1701
Business Address 2200 PENNSYLVANIA AVE. N.W. SUITE 800W WASHINGTON DC 20037-1701 2028280850
DANAHER CORP /DE/ (Filer) CIK: 0000313616 (see all company filings)

IRS No.: 591995548 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-08089 | Film No.: 20763715
SIC: 3823 Industrial Instruments For Measurement, Display, and Control